BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8252158)

  • 1. Acetylator polymorphism in Alzheimer's disease.
    Ladero JM; Barquero MS; Coria F; Molina JA; Jiménez-Jiménez FJ; Benítez J
    Eur J Med; 1993 May; 2(5):281-3. PubMed ID: 8252158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phenotypes of oxidation and acetylation in Alzheimer's disease--preliminary report].
    Milejski P; Orzechowska-Juzwenko K; Niewiński P; Hurkacz M; Czarnik-Matusewicz H; Leszek J; Rudzik J; Grotthus B
    Psychiatr Pol; 2007; 41(2):261-9. PubMed ID: 17598435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator polymorphism in human colorectal carcinoma.
    Ladero JM; González JF; Benítez J; Vargas E; Fernández MJ; Baki W; Diaz-Rubio M
    Cancer Res; 1991 Apr; 51(8):2098-100. PubMed ID: 2009528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
    Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
    J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenilin-1 gene intronic polymorphism and late-onset Alzheimer's disease.
    Dursun E; Gezen-Ak D; Eker E; Ertan T; Engin F; Hanagasi H; Gürvit H; Emre M; Yilmazer S
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):268-73. PubMed ID: 19017784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylator polymorphism in multiple sclerosis.
    Ladero JM; Arroyo R; De Andrés C; Jiménez-Jiménez FJ; Molina JA; Varela de Seijas E; Giménez-Roldán S; Benítez J
    Acta Neurol Scand; 1994 Feb; 89(2):102-4. PubMed ID: 8191871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylator polymorphism in Parkinson's disease.
    Ladero JM; Jimenez FJ; Benitez J; Fernandez-Gundin MJ; Martinez C; Llerena A; Cobaleda J; Muñoz JJ
    Eur J Clin Pharmacol; 1989; 37(4):391-3. PubMed ID: 2598972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
    Sleegers K; Roks G; Theuns J; Aulchenko YS; Rademakers R; Cruts M; van Gool WA; Van Broeckhoven C; Heutink P; Oostra BA; van Swieten JC; van Duijn CM
    Brain; 2004 Jul; 127(Pt 7):1641-9. PubMed ID: 15130954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator polymorphism in rheumatoid arthritis.
    Ladero JM; Andres MP; Bañares A; Fernández B; Hernández C; Benítez J
    Eur J Clin Pharmacol; 1993; 45(3):279-81. PubMed ID: 8276055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is 'early onset dementia'?
    Miyoshi K
    Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylation polymorphism in lung cancer].
    Laredo Quesada JM; Jara Sánchez C; Benítez Rodríguez J; Fernández Gundín MJ; Vargas Castrillón E; Muñoz González JJ; Llerena Ruiz A; Cobaleda Polo J; Pérez-Manga G
    An Med Interna; 1991 Feb; 8(2):66-8. PubMed ID: 1893005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancer.
    Orzechowska-Juzwenko K; Niewiński P; Pawlik J; Milejski P; Dembowski J; Swiebodzki L; Lorenz J
    Mater Med Pol; 1994; 26(4):145-8. PubMed ID: 7666680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic acetylator phenotype in bladder cancer patients.
    Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC
    Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1alpha -889 C/T polymorphism in Turkish patients with late-onset Alzheimer's disease.
    Dursun E; Gezen-Ak D; Ertan T; Bilgiç B; Gürvit H; Emre M; Eker E; Engin F; Uysal O; Yilmazer S
    Dement Geriatr Cogn Disord; 2009; 27(1):82-7. PubMed ID: 19155622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental age as a risk factor in Alzheimer's disease.
    Corkin S; Growdon JH; Rasmussen SL
    Ann Neurol; 1983 Jun; 13(6):674-6. PubMed ID: 6881929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetics of late-onset Alzheimer's disease: vascular risk and beta-amyloid metabolism].
    Panza F; Solfrizzi V; D'Introno A; Capurso C; Colacicco AM; Torres F; Altomare E; Capurso A
    Recenti Prog Med; 2002 Sep; 93(9):489-97. PubMed ID: 12355988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic acetylator phenotype in diabetes mellitus.
    Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
    Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.
    Modrego PJ; Ferrández J
    Arch Neurol; 2004 Aug; 61(8):1290-3. PubMed ID: 15313849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia.
    Kölsch H; Jessen F; Freymann N; Kreis M; Hentschel F; Maier W; Heun R
    Neurosci Lett; 2005 Mar; 377(1):37-9. PubMed ID: 15722183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.